Maze Therapeutics, Inc. - MAZE

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q2 2026 · Q1 2026

Value (USD)

Total reported value ($000)

$1.835B

QoQ value delta ($000)

+$278.4M (+17.88%)

Implied price effect (QoQ)

-0.12%

Total shares

61,524,147

QoQ shares delta

+9,397,173 (+18.03%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q2 2026 data: 162 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
Frazier Life Sciences Management, L.P.	150,182	5,032,915	3.27%
TRV GP IV, LLC	133,502	4,473,958	52.63%
ARCH Venture Management, LLC	122,983	4,120,053	11.18%
Deep Track Capital, LP	111,379	3,732,569	1.62%
BlackRock, Inc.	104,524	3,502,841	0.0%
Jupiter Topco LLC	101,764	3,408,045	0.04%
JANUS HENDERSON GROUP PLC	85,280	2,858,876	0.04%
T. Rowe Price Investment Management, Inc.	77,694	2,603,682	0.05%
Logos Global Management LP	57,740	1,935,000	2.49%
VANGUARD CAPITAL MANAGEMENT LLC	53,062	1,778,222	0.0%
a16z Capital Management, L.L.C.	50,794	1,702,225	0.36%
Venrock Adviser, LLC	47,804	1,602,034	1.45%
Alphabet Inc.	41,435	1,388,583	0.04%
BRAIDWELL LP	34,018	1,140,040	1.26%
FARALLON CAPITAL MANAGEMENT, L.L.C.	33,057	1,107,814	0.15%
FMR LLC	31,539	1,056,959	0.0%
General Catalyst Group Management, LLC	30,911	1,035,910	16.4%
STATE STREET CORP	29,766	997,533	0.0%
DRIEHAUS CAPITAL MANAGEMENT LLC	28,493	954,886	0.17%
TRV GP V, LLC	28,371	950,800	5.69%
JPMORGAN CHASE & CO	27,995	964,011	0.0%
MARSHALL WACE, LLP	27,290	914,572	0.02%
CITADEL ADVISORS LLC	26,106	874,876	0.0%
GEODE CAPITAL MANAGEMENT, LLC	25,608	858,054	0.0%
Casdin Capital, LLC	25,180	843,857	1.26%